Oropharyngeal Space in Videolaryngoscopy

April 3, 2014 updated by: Barbe Pieters, Catharina Ziekenhuis Eindhoven

Oropharyngeal Space in Videolaryngoscopy: a Randomised Crossover Trial Measuring Remaining Space Adjacent to the Videolaryngoscope Blade

In this randomised crossover trial we measure the space between the right side of the laryngoscope blade and the right palatopharyngeal wall in a cohort of ASA I-III patients with a normal mouth opening. We compare the remaining spaces for seven different videolaryngoscopes and compare these to a classic Macintosh laryngoscope.

Study Overview

Detailed Description

Intubation using indirect videolaryngoscopy has many advantages over classic direct laryngoscopy using the Macintosh laryngoscope. There are many different videolaryngoscopes available, and the blade differs largely between videolaryngoscopes. Different size and angles of blades may have an impact on the space available for insertion of the endotracheal tube. The space between the blade and the palatopharyngeal wall may be reduced significantly, so that there is less room in the mouth to insert an endotracheal tube. Positioning and manoeuvring of the endotracheal tube may consequently be more difficult and may traumatize the pharynx as was described in a few case reports, especially when an endotracheal tube with a rigid stylet inserted was used.

Study Type

Interventional

Enrollment (Actual)

489

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Noord-Brabant
      • Eindhoven, Noord-Brabant, Netherlands, 5602 ZA
        • Catharina Ziekenhuis Eindhoven

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Informed patient consent
  • ASA I - III
  • Age > 18 years
  • Elective surgery, other than head and/or neck surgery
  • Pre-operative Mallampati I - III
  • BMI < 35 kg/m2
  • Fasted (≥6 hours)

Exclusion Criteria:

  • No informed patient consent
  • ASA ≥ IV
  • Age < 18 year
  • Emergency surgery, surgery of head and/of neck
  • Locoregional anaesthesia
  • Pre-operative Mallampati IV
  • BMI > 35 kg/m2
  • Fasted < 6 hours
  • Pre-operative expected difficult airway (restrict neck movement, thyromental distance < 65mm, retrognathia)
  • Bad, fragile dentition
  • Dental crowns and/or fixed partial denture

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: NON_RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
OTHER: Coopdech® videolaryngoscope
Coopdech® videolaryngoscope
Other Names:
  • Coopdech® videolaryngoscope (Daiken Medical, Osaka, Japan)
OTHER: C-MAC® videolaryngoscope
C-MAC ® videolaryngoscope
Other Names:
  • C-MAC ® videolaryngoscope (Karl Storz, Tuttlingen, Germany)
OTHER: McGrath® Series 5 videolaryngoscope
McGrath® Series 5 videolaryngoscope
Other Names:
  • McGrath® Series 5 (Aircraft Medical, Edinburgh, UK)
OTHER: Glidescope® Cobalt videolaryngoscope
Glidescope® Cobalt videolaryngoscope
Other Names:
  • Glidescope® Cobalt (Verathon, Bothell, USA)
OTHER: King Vision® videolaryngoscope
King Vision® videolaryngoscope
Other Names:
  • King Vision® videolaryngoscope (King Systems, Noblesville, IN, USA)
OTHER: Venner® videolaryngoscope
Venner® videolaryngoscope
Other Names:
  • Venner® videolaryngoscope (Venner Medical, Singapore, Republic of Singapore)
OTHER: McGrath MAC® videolaryngoscope
McGrath® MAC (Aircraft Medical, Edinburgh, UK)
Other Names:
  • McGrath® MAC (Aircraft Medical, Edinburgh, UK)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Palatopharyngeal distance
Time Frame: Participants will be followed during induction of anesthesia, an expected average of 10 min
Two laryngoscopes (one classic direct laryngoscope and one indirect videolaryngoscope) will subsequently be inserted into the patient's mouth at random order. With each laryngoscope the horizontal distance between the laryngoscope blade and mid-palatopharyngeal fold will be measured using an mm ruler.
Participants will be followed during induction of anesthesia, an expected average of 10 min

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difference in palatopharyngeal distance between videolaryngoscope and classic Macintosh laryngoscope
Time Frame: Participants will be followed during induction of anesthesia, an expected average of 10 min
Investigating how this space differs from the space that remains on the right side of the blade of the classic Macintosh laryngoscope and the palatopharyngeal wall in the same cohort of patients.
Participants will be followed during induction of anesthesia, an expected average of 10 min
Difference in palatopharyngeal distance between videolaryngoscopes
Time Frame: Participants will be followed during induction of anesthesia, an expected average of 10 min
Comparing the difference in remaining palatopharyngeal space between the different videolaryngoscopes.
Participants will be followed during induction of anesthesia, an expected average of 10 min
Cormack-Lehane score
Time Frame: Participants will be followed during induction of anesthesia, an expected average of 10 min
Registering difficulty of intubation (Cormack-Lehane score)
Participants will be followed during induction of anesthesia, an expected average of 10 min
Successful intubation
Time Frame: Participants will be followed during induction of anesthesia, an expected average of 10 min
Registering the number of successful intubations.
Participants will be followed during induction of anesthesia, an expected average of 10 min
Use of rigid stylet
Time Frame: Participants will be followed during induction of anesthesia, an expected average of 10 min
Use of rigid stylet during intubation
Participants will be followed during induction of anesthesia, an expected average of 10 min
Number of attempts
Time Frame: Participants will be followed during induction of anesthesia, an expected average of 10 min
Number of intubation attempts
Participants will be followed during induction of anesthesia, an expected average of 10 min
Time until picking up endotracheal tube
Time Frame: Participants will be followed during induction of anesthesia, an expected average of 10 min
Time until picking up endotracheal tube
Participants will be followed during induction of anesthesia, an expected average of 10 min
Epiglottic down-folding
Time Frame: Participants will be followed during induction of anesthesia, an expected average of 10 min
Occurrence of epiglottic down-folding
Participants will be followed during induction of anesthesia, an expected average of 10 min
Complications
Time Frame: Participants will be followed during induction of anesthesia, an expected average of 10 min
Any complication that occurs during intubation will be registered.
Participants will be followed during induction of anesthesia, an expected average of 10 min

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2012

Primary Completion (ACTUAL)

April 1, 2014

Study Completion (ACTUAL)

April 1, 2014

Study Registration Dates

First Submitted

May 24, 2012

First Submitted That Met QC Criteria

May 29, 2012

First Posted (ESTIMATE)

May 31, 2012

Study Record Updates

Last Update Posted (ESTIMATE)

April 4, 2014

Last Update Submitted That Met QC Criteria

April 3, 2014

Last Verified

April 1, 2014

More Information

Terms related to this study

Other Study ID Numbers

  • M12-1210 (OTHER: Catharina Ziekenhuis Eindhoven)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intubation Complication

Clinical Trials on Coopdech® videolaryngoscope

Subscribe